Boston Scientific Corporation - BSX-PA

BSX-PA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BSX-PA	0	0	2.4	2.2	6.4	20.4	16.7	17.5	17.5	17.5
S&P 500	-1.4	-1.8	0.9	5.8	10.5	30.3	25.3	88.0	187.4	33123.8

Compare BSX-PA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BSX-PA
name	Boston Scientific Corporation
price	122.18
changes percentage	2.3712
change	2.83
day low	119.7
day high	123.27
year high	129.12
year low	97.37
market cap	175448396220
price avg 50	123.426994
price avg 200	114.02877
exchange	NYSE
volume	2056126
avg volume	191486
open	119.7
previous close	119.35
eps	0.53
pe	230.528302
earnings announcement	2023-03-31T00:00:00.000+0000
shares outstanding	1435982945
timestamp	2023-05-31 20:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 67.7%

Overall Quarterly Financial Health: 52.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000885725
revenue	14240000000	12682000000	12.29
gross profit	9895000000	8679000000	14.01
gross profit ratio	0.69	0.68	1.54
research and development expenses	1414000000	1323000000	6.88
operating expenses	7478000000	6646000000	12.52
interest income	22000000	10000000	120.00
interest expense	265000000	470000000	-43.62
ebitda	3453000000	2741000000	25.98
ebitdaratio	0.24	0.22	9.83
operating income	2343000000	1649000000	42.09
operating income ratio	0.16	0.13	26.54
net income	1593000000	698000000	128.22
net income ratio	0.11	0.06	103.25
eps	1.08	0.45	140.00

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 14,240 million in 2023 from 12,682 million in 2022 representing a change of 12.29%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 9,895 million in 2023 from 8,679 million in 2022 representing a change of 14.01%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 1,414 million in 2023 from 1,323 million in 2022 representing a change of 6.88%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 3,453 million in 2023 from 2,741 million in 2022 representing a change of 25.98%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 2,343 million in 2023 from 1,649 million in 2022 representing a change of 42.09%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 1.08 in 2023 from 1.08 in 2022 representing a change of 140.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 7,478 million in 2023 from 6,646 million in 2022 representing a change of 12.52%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 1,593 million in 2023 from 698 million in 2022 representing a change of 128.22%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000885725
revenue	4209000000	4120000000	2.16
gross profit	2648000000	2585000000	2.44
gross profit ratio	0.63	0.63	0.27
research and development expenses	407000000	383000000	6.27
operating expenses	1969000000	1838000000	7.13
interest income	0	0	NaN
interest expense	79000000	77000000	2.60
ebitda	1058000000	812000000	30.30
ebitdaratio	0.25	0.26	-2.11
operating income	733000000	747000000	-1.87
operating income ratio	0.17	0.18	-3.95
net income	468000000	324000000	44.44
net income ratio	0.11	0.08	41.39
eps	0.32	0.22	45.45

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 4,209 million in 2024Q3 from 4,120 million in 2024Q2 representing a change of 2.16%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,648 million in 2024Q3 from 2,585 million in 2024Q2 representing a change of 2.44%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 407 million in 2024Q3 from 383 million in 2024Q2 representing a change of 6.27%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Net Income: Net income increased to 468 million in 2024Q3 from 324 million in 2024Q2 representing a change of 44.44%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.32 in 2024Q3 from 0.32 in 2024Q2 representing a change of 45.45%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 1,969 million in 2024Q3 from 1,838 million in 2024Q2 representing a change of 7.13%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,058 million in 2024Q3 from 812 million in 2024Q2 representing a change of 30.3%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 733 million in 2024Q3 from 747 million in 2024Q2 representing a change of -1.87%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000885725
total assets	35136000000	32470000000	8.21
total liabilities	15606000000	14896000000	4.77
total equity	19530000000	17574000000	11.13
cash and cash equivalents	865000000	928000000	-6.79
short term investments	0	0	NaN
long term investments	413000000	407000000	1.47
total current assets	6514000000	5760000000	13.09
total non current assets	28622000000	26710000000	7.16
total current liabilities	4933000000	3803000000	29.71
total non current liabilities	10673000000	11093000000	-3.79
common stock	17000000	17000000	0.00
retained earnings	819000000	-750000000	209.20
total debt	9492000000	9282000000	2.26

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 35,136 million in 2023 from 32,470 million in 2022 representing a change of 8.21%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 19,530 million in 2023 from 17,574 million in 2022 representing a change of 11.13%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 6,514 million in 2023 from 5,760 million in 2022 representing a change of 13.09%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 819 million in 2023 from -750 million in 2022 representing a change of 209.2%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 15,606 million in 2023 from 14,896 million in 2022 representing a change of 4.77%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 865 million in 2023 from 928 million in 2022 representing a change of -6.79%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 4,933 million in 2023 from 3,803 million in 2022 representing a change of 29.71%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 9,492 million in 2023 from 9,282 million in 2022 representing a change of 2.26%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000885725
total assets	38078000000	37108000000	2.61
total liabilities	17122000000	16498000000	3.78
total equity	20956000000	20609000000	1.68
cash and cash equivalents	2502000000	2988000000	-16.27
short term investments	70000000	0	NaN
long term investments	532000000	589000000	-9.68
total current assets	8761000000	8991000000	-2.56
total non current assets	29317000000	28117000000	4.27
total current liabilities	5910000000	5576000000	5.99
total non current liabilities	11212000000	10922000000	2.66
common stock	17000000	17000000	0.00
retained earnings	2107000000	1639000000	28.55
total debt	11258000000	10936000000	2.94

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 38,078 million in 2024Q3 from 37,108 million in 2024Q2 representing a change of 2.61%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 20,956 million in 2024Q3 from 20,609 million in 2024Q2 representing a change of 1.68%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 70 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Retained Earnings: Retained Earnings increased to 2,107 million in 2024Q3 from 1,639 million in 2024Q2 representing a change of 28.55%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 17,122 million in 2024Q3 from 16,498 million in 2024Q2 representing a change of 3.78%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2,502 million in 2024Q3 from 2,988 million in 2024Q2 representing a change of -16.27%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 8,761 million in 2024Q3 from 8,991 million in 2024Q2 representing a change of -2.56%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 5,910 million in 2024Q3 from 5,576 million in 2024Q2 representing a change of 5.99%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 11,258 million in 2024Q3 from 10,936 million in 2024Q2 representing a change of 2.94%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000885725
net change in cash	-71000000	-1042000000	93.19
operating cash flow	2503000000	1526000000	64.02
free cash flow	1703000000	914000000	86.32
capital expenditure	-800000000	-612000000	-30.72
depreciation and amortization	1196000000	1136000000	5.28
deferred income tax	-1000000	-63000000	98.41
stock based compensation	233000000	220000000	5.91
accounts payables	118000000	-255000000	146.27
inventory	-660000000	-321000000	-105.61
acquisitions net	-1811000000	-1537000000	-17.83
investments in property plant and equipment	-711000000	-612000000	-16.18
net cash used for investing activites	-2574000000	-2011000000	-28.00
debt repayment	-4000000	-165000000	97.58
common stock issued	182000000	0	NaN
common stock repurchased	182000000	136000000	33.82
dividends paid	-28000000	-55000000	49.09
net cash used provided by financing activities	5000000	-548000000	100.91
cash at end of period	1055000000	1126000000	-6.31
accounts receivables	-238000000	-220000000	-8.18
cash at beginning of period	1126000000	2168000000	-48.06

Overall Score of Annual Cashflow Statement

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -71 million in 2023 from -1,042 million in 2022 representing a change of 93.19%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,503 million in 2023 from 1,526 million in 2022 representing a change of 64.02%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,703 million in 2023 from 914 million in 2022 representing a change of 86.32%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -800 million in 2023 from -612 million in 2022 representing a change of -30.72%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 118 million in 2023 from 255 million in 2022 representing a change of 146.27%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -238 million in 2023 from -220 million in 2022 representing a change of -8.18%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -28 million in 2023 from -55 million in 2022 representing a change of 49.09%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -1 million in 2023 from -63 million in 2022 representing a change of 98.41%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 233 million in 2023 from 220 million in 2022 representing a change of 5.91%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000885725
operating cash flow	-1142847000000	813000000	-140671.59
free cash flow	-1143239000000	658000000	-173844.53
capital expenditure	-392000000	-155000000	-152.90
depreciation and amortization	636000000	311000000	104.50
deferred income tax	-11000000	-10000000	-10.00
stock based compensation	-1144224000000	195000000	-586881.54
accounts receivables	-175000000	-114000000	-53.51
accounts payables	69000000	71000000	-2.82
inventory	-89000000	-95000000	6.32
acquisitions net	-1127000000	-48000000	-2247.92
investments in property plant and equipment	-179000000	-155000000	-15.48
net cash used for investing activites	-1427000000	-271000000	-426.57
debt repayment	22000000	0	NaN
common stock issued	96000000	26000000	269.23
common stock repurchased	0	0	NaN
dividends paid	-23000000	0	NaN
net cash used provided by financing activities	1678000000	24000000	6891.67
net change in cash	-1141978000000	566000000	-201862.90
cash at end of period	2649000000	2988000000	-11.35
cash at beginning of period	1144627000000	2422000000	47159.58

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,141,978 million in 2024Q3 from 566 million in 2024Q2 representing a change of -201862.9%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -1,142,847 million in 2024Q3 from 813 million in 2024Q2 representing a change of -140671.59%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -1,143,239 million in 2024Q3 from 658 million in 2024Q2 representing a change of -173844.53%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid decreased to -23 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -392 million in 2024Q3 from -155 million in 2024Q2 representing a change of -152.9%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to -1,144,224 million in 2024Q3 from 195 million in 2024Q2 representing a change of -586881.54%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 69 million in 2024Q3 from 71 million in 2024Q2 representing a change of -2.82%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -175 million in 2024Q3 from -114 million in 2024Q2 representing a change of -53.51%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	9.8	8.87	10.55
net income per share	1.1	0.49	124.69
operating cash flow per share	1.72	1.07	61.48
free cash flow per share	1.17	0.64	83.44
cash per share	0.6	0.65	-8.23
book value per share	13.44	12.29	9.41
tangible book value per share	-0.59	-0.87	32.21
shareholders equity per share	13.27	12.29	8.02
interest debt per share	6.44	6.57	-1.95
market cap	83997930000	66189235000.0	26.91
enterprise value	92624930000	74543235000	24.26
pe ratio	52.73	94.83	-44.39
price to sales ratio	5.9	5.22	13.02
pocfratio	33.56	43.37	-22.63
pfcf ratio	49.32	72.42	-31.89
pb ratio	4.36	3.77	15.66
ptb ratio	4.36	3.77	15.66
ev to sales	6.5	5.88	10.66
enterprise value over ebitda	26.82	27.2	-1.36
ev to operating cash flow	37.01	48.85	-24.24
ev to free cash flow	54.39	81.56	-33.31
earnings yield	0.02	0.01	79.84
free cash flow yield	0.02	0.01	46.82
debt to equity	0.47	0.51	-7.15
debt to assets	0.26	0.28	-5.86
net debt to ebitda	2.5	3.05	-18.03
current ratio	1.32	1.51	-12.82
interest coverage	8.84	3.51	152.00
income quality	1.57	2.19	-28.09
dividend yield	0.0	0.0	-59.88
payout ratio	0.02	0.08	-77.69
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.1	0.1	-4.82
intangibles to total assets	0.58	0.58	0.11
capex to operating cash flow	0.32	0.4	-20.30
capex to revenue	0.06	0.05	16.42
capex to depreciation	0.67	0.54	24.16
stock based compensation to revenue	0.02	0.02	-5.68
graham number	18.09	11.61	55.79
roic	0.07	0.04	73.97
return on tangible assets	0.11	0.05	111.21
graham net net	-8.14	-8.08	-0.76
working capital	1581000000	1957000000	-19.21
tangible asset value	-860000000	-1249000000	31.14
net current asset value	-9092000000	-9136000000	0.48
invested capital	25269000000	23611000000	7.02
average receivables	2099000000	1874000000	12.01
average payables	902000000	828000000	8.94
average inventory	2175500000	1738500000	25.14
days sales outstanding	57.11	56.7	0.72
days payables outstanding	79.13	78.6	0.68
days of inventory on hand	208.67	170.24	22.58
receivables turnover	6.39	6.44	-0.72
payables turnover	4.61	4.64	-0.67
inventory turnover	1.75	2.14	-18.42
roe	0.08	0.04	108.01
capex per share	0.55	0.43	28.69

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 52.73 on 2023-12-31 from 94.83 on 2022-12-31, representing a change of -44.39%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.32 on 2023-12-31 from 1.51 on 2022-12-31, representing a change of -12.82%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.47 on 2023-12-31 from 0.51 on 2022-12-31, representing a change of -7.15%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BSX-PA
calendar year	2024	2024	NaN
revenue per share	2.86	2.8	2.01
net income per share	0.32	0.22	44.24
operating cash flow per share	-776.02	0.55	-140471.14
free cash flow per share	-776.29	0.45	-173596.78
cash per share	1.75	2.03	-14.05
book value per share	14.23	14.01	1.53
tangible book value per share	0.11	0.54	-78.80
shareholders equity per share	14.06	13.85	1.51
interest debt per share	7.44	7.24	2.82
market cap	123412260000	112368546000	9.83
enterprise value	132168260000	120316546000	9.85
pe ratio	65.93	86.7	-23.97
price to sales ratio	29.32	27.27	7.51
pocfratio	-0.11	138.21	-100.08
pfcf ratio	-0.11	170.77	-100.06
pb ratio	5.96	5.52	8.04
ptb ratio	5.96	5.52	8.04
ev to sales	31.4	29.2	7.53
enterprise value over ebitda	124.92	148.17	-15.69
ev to operating cash flow	-0.12	147.99	-100.08
ev to free cash flow	-0.12	182.85	-100.06
earnings yield	0.0	0.0	31.52
free cash flow yield	-9.26	0.01	-158296.76
debt to equity	0.53	0.52	1.30
debt to assets	0.29	0.28	0.35
net debt to ebitda	8.28	9.79	-15.45
current ratio	1.48	1.61	-8.06
interest coverage	9.28	9.7	-4.36
income quality	-1632.64	2.51	-65164.56
dividend yield	0.0	0	NaN
payout ratio	0.05	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.1	0.09	4.02
intangibles to total assets	0.55	0.53	2.24
capex to operating cash flow	-0.0	0.19	-100.18
capex to revenue	0.09	0.04	147.56
capex to depreciation	0.62	0.5	23.67
stock based compensation to revenue	-271.85	0.05	-574473.95
graham number	10.03	8.29	21.00
roic	0.02	0.02	-12.12
return on tangible assets	0.03	0.02	44.47
graham net net	-7.67	-7.08	-8.41
working capital	2851000000	3415000000	-16.52
tangible asset value	169000000	796000000	-78.77
net current asset value	-8361000000	-7507000000	-11.38
invested capital	27136000000	26596000000	2.03
average receivables	2450500000	2352000000	4.19
average payables	906500000	913500000	-0.77
average inventory	2680500000	2584500000	3.71
days sales outstanding	53.48	52.43	2.00
days payables outstanding	52.29	53.12	-1.56
days of inventory on hand	158.73	152.91	3.80
receivables turnover	1.68	1.72	-1.97
payables turnover	1.72	1.69	1.58
inventory turnover	0.57	0.59	-3.66
roe	0.02	0.02	42.09
capex per share	0.27	0.11	152.54

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of 42.09%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 65.93 on 2024-09-30 Q3 from 86.70 on 2024-06-30 Q2, representing a change of -23.97%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.48 on 2024-09-30 Q3 from 1.61 on 2024-06-30 Q2, representing a change of -8.06%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.53 on 2024-09-30 Q3 from 0.52 on 2024-06-30 Q2, representing a change of 1.30%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None